ArticleThe oncologist2025

Phase Ib study of anti-PD-L1 monoclonal antibody socazolimab in combination with nab-paclitaxel as first-line therapy for advanced urothelial carcinoma.

Bixia Tang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.